Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers

VA Jespers, JM Van Roey, GI Beets, AM Buvé

    Research output: Contribution to journalA1: Web of Science-article

    Original languageEnglish
    JournalJournal of Acquired Immune Deficiency Syndromes
    Volume44
    Issue number2
    Pages (from-to)154-158
    ISSN1525-4135
    DOIs
    Publication statusPublished - 2007

    Keywords

    • B780-tropical-medicine
    • Viral diseases
    • HIV
    • AIDS
    • Prevention strategies
    • Microbicides
    • Safety
    • Tolerability
    • Dosage
    • Clinical trials

    Cite this